更多...
收起
This gene encodes a protein that belongs to the pi3/pi4-kinase family of proteins. The gene product is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. It is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In addition to its role in promoting assembly of adherens junctions, the protein is thought to play a pivotal role in the regulation of cytotoxicity in NK cells. The gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2013]
[中文简述(自动翻译):]  这个基因编码属于蛋白质的PI3 / PI4激酶家族的蛋白。的基因产物是磷酸的肌醇环的3-羟基磷酸肌醇的酶。它是细胞外的信号,包括由E-钙粘蛋白介导的细胞 - 细胞粘附,这在维护上皮的结构和功能完整性的起着重要的作用引起的重要调节剂。除了其在促进粘着结组件的作用,该蛋白质被认为发挥细胞毒性的中NK细胞的调节了关键作用。该基因位于先前在骨髓性白血病染色体鉴定7的共同缺失段。已发现了该基因编码相同的蛋白质几个抄本变形。 [由RefSeq的,2013年9月提供]
PIK3CG基因(以及对应的蛋白质)的细胞分布位置:
PIK3CG基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Fibrosis | 0.2 | 2 | 0 | CTD_human_RGD |
Diffuse Large B-Cell Lymphoma | 0.122714419 | 10 | 0 | BeFree_CTD_human |
Medulloblastoma | 0.122171535 | 8 | 0 | BeFree_CTD_human |
Heart failure | 0.121357209 | 6 | 0 | BeFree_CTD_human |
Autistic Disorder | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Cardiomegaly | 0.12 | 1 | 0 | CTD_human |
Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
Inflammation | 0.08 | 1 | 0 | RGD |
Malignant neoplasm of breast | 0.047426383 | 167 | 0 | BeFree_GAD |
Breast Carcinoma | 0.043973583 | 162 | 0 | BeFree |
Carcinogenesis | 0.035287443 | 130 | 0 | BeFree |
melanoma | 0.016839328 | 53 | 1 | BeFree_LHGDN |
Malignant neoplasm of prostate | 0.016829396 | 62 | 0 | BeFree |
Prostate carcinoma | 0.016829396 | 62 | 0 | BeFree |
Ovarian Carcinoma | 0.015743629 | 58 | 0 | BeFree |
Glioblastoma | 0.015200745 | 56 | 0 | BeFree |
Neoplasm Metastasis | 0.015200745 | 56 | 0 | BeFree |
Glioma | 0.014677724 | 36 | 0 | BeFree_LHGDN |
Mammary Neoplasms | 0.013883262 | 15 | 0 | BeFree_LHGDN |
Liver carcinoma | 0.013843535 | 51 | 0 | BeFree |
Malignant neoplasm of ovary | 0.01302921 | 48 | 0 | BeFree |
Colorectal Carcinoma | 0.011943442 | 44 | 1 | BeFree |
Colorectal Cancer | 0.011943442 | 44 | 1 | BeFree |
Non-Small Cell Lung Carcinoma | 0.011672 | 43 | 0 | BeFree |
Endometrial Carcinoma | 0.011672 | 43 | 0 | BeFree |
Stomach Carcinoma | 0.011129117 | 41 | 0 | BeFree |
Malignant neoplasm of stomach | 0.010314791 | 38 | 0 | BeFree |
Malignant neoplasm of lung | 0.008957582 | 33 | 1 | BeFree |
leukemia | 0.00842463 | 22 | 1 | BeFree_LHGDN |
Leukemia, Myelocytic, Acute | 0.008143256 | 30 | 0 | BeFree |
Carcinoma of lung | 0.008143256 | 30 | 1 | BeFree |
Renal Cell Carcinoma | 0.007610304 | 18 | 0 | BeFree_LHGDN |
Malignant tumor of colon | 0.007328931 | 27 | 0 | BeFree |
Colon Carcinoma | 0.007057489 | 26 | 0 | BeFree |
Prostatic Neoplasms | 0.00680591 | 6 | 0 | BeFree_LHGDN |
Malignant neoplasm of pancreas | 0.006786047 | 25 | 0 | BeFree |
Pancreatic carcinoma | 0.006514605 | 24 | 0 | BeFree |
Thyroid carcinoma | 0.006514605 | 24 | 0 | BeFree |
Squamous cell carcinoma | 0.006253095 | 14 | 0 | BeFree_LHGDN |
Colonic Neoplasms | 0.005991584 | 4 | 0 | BeFree_LHGDN |
Colorectal Neoplasms | 0.005991584 | 4 | 0 | BeFree_LHGDN |
Malignant neoplasm of endometrium | 0.005971721 | 22 | 0 | BeFree |
Uterine Corpus Cancer | 0.005971721 | 22 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.005700279 | 21 | 0 | BeFree |
Myeloid Leukemia, Chronic | 0.005438769 | 10 | 0 | BeFree_LHGDN |
Neuroblastoma | 0.005428837 | 20 | 0 | BeFree |
Central neuroblastoma | 0.005157396 | 19 | 0 | BeFree |
Rheumatoid Arthritis | 0.004624443 | 8 | 0 | BeFree_LHGDN |
Thyroid Neoplasm | 0.004624443 | 8 | 1 | BeFree_LHGDN |
Squamous cell carcinoma of the head and neck | 0.004614512 | 17 | 0 | BeFree |
Multiple Myeloma | 0.00434307 | 16 | 0 | BeFree |
Tumor Progression | 0.00434307 | 16 | 0 | BeFree |
B-Cell Lymphomas | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Epithelial ovarian cancer | 0.004071628 | 15 | 0 | BeFree |
HIV Infections | 0.003995683 | 7 | 0 | BeFree_GAD |
Chondrosarcoma | 0.003810118 | 5 | 0 | BeFree_LHGDN |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.003800186 | 14 | 0 | BeFree |
Hodgkin Disease | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Malignant neoplasm of urinary bladder | 0.003528744 | 13 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.003257302 | 12 | 0 | BeFree |
Osteosarcoma | 0.003257302 | 12 | 0 | BeFree |
Osteosarcoma of bone | 0.003257302 | 12 | 0 | BeFree |
Carcinoma of bladder | 0.003257302 | 12 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.003257302 | 12 | 0 | BeFree |
Nephroblastoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Stomach Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Malignant tumor of cervix | 0.002985861 | 11 | 0 | BeFree |
Cervix carcinoma | 0.002985861 | 11 | 0 | BeFree |
Nasopharyngeal carcinoma | 0.002985861 | 11 | 0 | BeFree |
Hepatitis C | 0.002909916 | 3 | 0 | BeFree_GAD |
Bacterial Infections | 0.00272435 | 1 | 0 | LHGDN |
Pertussis | 0.00272435 | 1 | 0 | LHGDN |
Infection | 0.00272435 | 1 | 0 | LHGDN |
Lymphoma | 0.002714419 | 10 | 0 | BeFree |
Tuberous Sclerosis | 0.002714419 | 10 | 0 | BeFree |
Solid tumour | 0.002714419 | 10 | 0 | BeFree |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.002714419 | 10 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.002714419 | 10 | 1 | BeFree |
Insulin Resistance | 0.002367032 | 1 | 0 | GAD |
Obesity, Morbid | 0.002367032 | 1 | 0 | GAD |
Platelet mean volume finding | 0.002367032 | 1 | 1 | GAD |
Obesity | 0.002171535 | 8 | 0 | BeFree |
Thymoma | 0.002171535 | 8 | 1 | BeFree |
Adenocarcinoma of lung (disorder) | 0.002171535 | 8 | 0 | BeFree |
Rhabdoid Tumor of the Kidney | 0.002171535 | 8 | 0 | BeFree |
Xenograft Model | 0.002171535 | 8 | 2 | BeFree |
Diabetes Mellitus, Non-Insulin-Dependent | 0.001900093 | 7 | 5 | BeFree |
Ischemia | 0.001900093 | 7 | 0 | BeFree |
Acute lymphocytic leukemia | 0.001900093 | 7 | 0 | BeFree |
Liver neoplasms | 0.001900093 | 7 | 0 | BeFree |
Follicular thyroid carcinoma | 0.001900093 | 7 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.001900093 | 7 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.001900093 | 7 | 0 | BeFree |
Papillary thyroid carcinoma | 0.001900093 | 7 | 0 | BeFree |
Carcinoma breast stage IV | 0.001900093 | 7 | 0 | BeFree |
Tumor Angiogenesis | 0.001900093 | 7 | 0 | BeFree |
Adenocarcinoma | 0.001628651 | 6 | 0 | BeFree |
Diabetes Mellitus | 0.001628651 | 6 | 0 | BeFree |
Rhabdomyosarcoma | 0.001628651 | 6 | 0 | BeFree |
Leukemogenesis | 0.001628651 | 6 | 0 | BeFree |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.001628651 | 6 | 0 | BeFree |
Diabetes | 0.001357209 | 5 | 0 | BeFree |
Congestive heart failure | 0.001357209 | 5 | 0 | BeFree |
Influenza | 0.001357209 | 5 | 0 | BeFree |
Myeloid Leukemia | 0.001357209 | 5 | 0 | BeFree |
Retinoblastoma | 0.001357209 | 5 | 0 | BeFree |
Virus Diseases | 0.001357209 | 5 | 0 | BeFree |
Renal carcinoma | 0.001357209 | 5 | 0 | BeFree |
Glioblastoma Multiforme | 0.001357209 | 5 | 0 | BeFree |
Arteriosclerosis | 0.001085767 | 4 | 0 | BeFree |
Atherosclerosis | 0.001085767 | 4 | 0 | BeFree |
Brain Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Endometriosis | 0.001085767 | 4 | 0 | BeFree |
Mesothelioma | 0.001085767 | 4 | 0 | BeFree |
Myocardial Infarction | 0.001085767 | 4 | 0 | BeFree |
Pancreatic Neoplasm | 0.001085767 | 4 | 0 | BeFree |
Acute leukemia | 0.001085767 | 4 | 0 | BeFree |
Small cell carcinoma of lung | 0.001085767 | 4 | 0 | BeFree |
Esophageal carcinoma | 0.001085767 | 4 | 0 | BeFree |
Neuroendocrine Tumors | 0.001085767 | 4 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.001085767 | 4 | 0 | BeFree |
Hematologic Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of esophagus | 0.001085767 | 4 | 0 | BeFree |
Ewings sarcoma | 0.001085767 | 4 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.001085767 | 4 | 0 | BeFree |
Cancer Cell Growth | 0.001085767 | 4 | 0 | BeFree |
Asthma | 0.000814326 | 3 | 0 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Carcinoma, Transitional Cell | 0.000814326 | 3 | 0 | BeFree |
Chordoma | 0.000814326 | 3 | 0 | BeFree |
Colitis | 0.000814326 | 3 | 0 | BeFree |
Coronary Arteriosclerosis | 0.000814326 | 3 | 5 | BeFree |
Esophageal Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Hamartoma Syndrome, Multiple | 0.000814326 | 3 | 0 | BeFree |
Heart Diseases | 0.000814326 | 3 | 0 | BeFree |
Immune System Diseases | 0.000814326 | 3 | 0 | BeFree |
Lung Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Neurilemmoma | 0.000814326 | 3 | 0 | BeFree |
Pulmonary Fibrosis | 0.000814326 | 3 | 0 | BeFree |
Schizophrenia | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of mouth | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of brain | 0.000814326 | 3 | 0 | BeFree |
Carcinoma, Endometrioid | 0.000814326 | 3 | 0 | BeFree |
Macrocephaly | 0.000814326 | 3 | 0 | BeFree |
Metastatic melanoma | 0.000814326 | 3 | 0 | BeFree |
Cancer of Head and Neck | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma of pancreas | 0.000814326 | 3 | 0 | BeFree |
Tumor Initiation | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000814326 | 3 | 0 | BeFree |
Helicobacter pylori infection | 0.000814326 | 3 | 0 | BeFree |
Invasive breast carcinoma | 0.000814326 | 3 | 0 | BeFree |
Sarcoma | 0.000814326 | 3 | 0 | BeFree |
Hepatocarcinogenesis | 0.000814326 | 3 | 0 | BeFree |
Idiopathic Pulmonary Fibrosis | 0.000814326 | 3 | 0 | BeFree |
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | 0.000814326 | 3 | 0 | BeFree |
Urothelial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Congenital Abnormality | 0.000542884 | 2 | 0 | BeFree |
Primary Myelofibrosis | 0.000542884 | 2 | 0 | BeFree |
Arthritis | 0.000542884 | 2 | 0 | BeFree |
Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
Burkitt Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
Rectal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Merkel cell carcinoma | 0.000542884 | 2 | 0 | BeFree |
Choriocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Coronary heart disease | 0.000542884 | 2 | 5 | BeFree |
Diabetic Nephropathy | 0.000542884 | 2 | 0 | BeFree |
Ependymoma | 0.000542884 | 2 | 0 | BeFree |
Fragile X Syndrome | 0.000542884 | 2 | 0 | BeFree |
Hamartoma | 0.000542884 | 2 | 0 | BeFree |
Atrial Septal Defects | 0.000542884 | 2 | 0 | BeFree |
Herpes Simplex Infections | 0.000542884 | 2 | 0 | BeFree |
Hypertensive disease | 0.000542884 | 2 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.000542884 | 2 | 0 | BeFree |
Kidney Neoplasm | 0.000542884 | 2 | 0 | BeFree |
liposarcoma | 0.000542884 | 2 | 0 | BeFree |
Liver Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
Lymphoproliferative Disorders | 0.000542884 | 2 | 0 | BeFree |
Myelofibrosis | 0.000542884 | 2 | 0 | BeFree |
Myeloproliferative disease | 0.000542884 | 2 | 0 | BeFree |
Neurofibromatosis 1 | 0.000542884 | 2 | 0 | BeFree |
Pituitary Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Adenomatous Polyposis Coli | 0.000542884 | 2 | 0 | BeFree |
Psoriasis | 0.000542884 | 2 | 0 | BeFree |
Cerebrovascular accident | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of nasopharynx | 0.000542884 | 2 | 0 | BeFree |
Anaplastic carcinoma | 0.000542884 | 2 | 0 | BeFree |
Ki-1+ Anaplastic Large Cell Lymphoma | 0.000542884 | 2 | 0 | BeFree |
Hepatoblastoma | 0.000542884 | 2 | 0 | BeFree |
Rhabdomyosarcoma, Embryonal | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma, Clear Cell | 0.000542884 | 2 | 0 | BeFree |
Cholangiocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Cystadenocarcinoma, Serous | 0.000542884 | 2 | 0 | BeFree |
Uveal melanoma | 0.000542884 | 2 | 0 | BeFree |
Cancer of Nasopharynx | 0.000542884 | 2 | 0 | BeFree |
Medullary carcinoma of thyroid | 0.000542884 | 2 | 0 | BeFree |
Age related macular degeneration | 0.000542884 | 2 | 0 | BeFree |
Inflammatory Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Conventional (Clear Cell) Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of liver | 0.000542884 | 2 | 0 | BeFree |
Malignant mesothelioma | 0.000542884 | 2 | 0 | BeFree |
Hemimegalencephaly | 0.000542884 | 2 | 0 | BeFree |
Metabolic Syndrome X | 0.000542884 | 2 | 0 | BeFree |
Malignant Glioma | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.000542884 | 2 | 0 | BeFree |
Advanced cancer | 0.000542884 | 2 | 0 | BeFree |
Erdheim-Chester Disease | 0.000542884 | 2 | 0 | BeFree |
ovarian neoplasm | 0.000542884 | 2 | 0 | BeFree |
Metastatic Prostate Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Colorectal cancer metastatic | 0.000542884 | 2 | 1 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000542884 | 2 | 0 | BeFree |
Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
Coronary Artery Disease | 0.000542884 | 2 | 5 | BeFree |
Philadelphia chromosome-positive acute lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
ESTROGEN RESISTANCE | 0.000542884 | 2 | 0 | BeFree |
Alcoholic Intoxication, Chronic | 0.000271442 | 1 | 0 | BeFree |
Alzheimer's Disease | 0.000271442 | 1 | 0 | BeFree |
Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Dilated | 0.000271442 | 1 | 0 | BeFree |
Cardiovascular Diseases | 0.000271442 | 1 | 0 | BeFree |
Cerebral Infarction | 0.000271442 | 1 | 0 | BeFree |
Chikungunya Fever | 0.000271442 | 1 | 0 | BeFree |
Cholestasis | 0.000271442 | 1 | 0 | BeFree |
Congenital chromosomal disease | 0.000271442 | 1 | 0 | BeFree |
Cystadenoma | 0.000271442 | 1 | 0 | BeFree |
Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
Dermatitis | 0.000271442 | 1 | 0 | BeFree |
Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Fetal Alcohol Syndrome | 0.000271442 | 1 | 0 | BeFree |
Fibrosarcoma | 0.000271442 | 1 | 0 | BeFree |
IGA Glomerulonephritis | 0.000271442 | 1 | 0 | BeFree |
granulosa cell tumor | 0.000271442 | 1 | 0 | BeFree |
Graves Disease | 0.000271442 | 1 | 0 | BeFree |
Hemangiosarcoma | 0.000271442 | 1 | 0 | BeFree |
Von Hippel-Lindau Syndrome | 0.000271442 | 1 | 0 | BeFree |
Histiocytosis, Langerhans-Cell | 0.000271442 | 1 | 0 | BeFree |
Hyperglycemia | 0.000271442 | 1 | 0 | BeFree |
Hypoglycemia | 0.000271442 | 1 | 0 | BeFree |
insulinoma | 0.000271442 | 1 | 0 | BeFree |
Intestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Intestinal Pseudo-Obstruction | 0.000271442 | 1 | 0 | BeFree |
Keloid | 0.000271442 | 1 | 0 | BeFree |
leiomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Acute Erythroblastic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Hairy Cell Leukemia | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Mast-Cell | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Myeloid, Chronic-Phase | 0.000271442 | 1 | 0 | BeFree |
Leukemia, T-Cell | 0.000271442 | 1 | 0 | BeFree |
Adult T-Cell Lymphoma/Leukemia | 0.000271442 | 1 | 0 | BeFree |
Lipodystrophy | 0.000271442 | 1 | 0 | BeFree |
Lipomatosis | 0.000271442 | 1 | 0 | BeFree |
Liver diseases | 0.000271442 | 1 | 0 | BeFree |
Lupus Erythematosus, Systemic | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
Waldenstrom Macroglobulinemia | 0.000271442 | 1 | 0 | BeFree |
Mastocytosis | 0.000271442 | 1 | 0 | BeFree |
Multiple Endocrine Neoplasia Type 2b | 0.000271442 | 1 | 0 | BeFree |
Meningioma | 0.000271442 | 1 | 0 | BeFree |
Metabolic Diseases | 0.000271442 | 1 | 0 | BeFree |
Monosomy | 0.000271442 | 1 | 0 | BeFree |
Mycobacterium Infections | 0.000271442 | 1 | 0 | BeFree |
Mycosis Fungoides | 0.000271442 | 1 | 0 | BeFree |
Embryonal Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Neoplastic Syndromes, Hereditary | 0.000271442 | 1 | 0 | BeFree |
Degenerative polyarthritis | 0.000271442 | 1 | 0 | BeFree |
Papilloma | 0.000271442 | 1 | 0 | BeFree |
Paraganglioma | 0.000271442 | 1 | 0 | BeFree |
Pheochromocytoma | 0.000271442 | 1 | 0 | BeFree |
Pituitary Adenoma | 0.000271442 | 1 | 0 | BeFree |
Pneumonia | 0.000271442 | 1 | 0 | BeFree |
Polycystic Ovary Syndrome | 0.000271442 | 1 | 0 | BeFree |
Polycythemia Vera | 0.000271442 | 1 | 0 | BeFree |
Precancerous Conditions | 0.000271442 | 1 | 0 | BeFree |
Preleukemia | 0.000271442 | 1 | 0 | BeFree |
Systemic Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Seizures | 0.000271442 | 1 | 0 | BeFree |
Septicemia | 0.000271442 | 1 | 0 | BeFree |
Dermatologic disorders | 0.000271442 | 1 | 0 | BeFree |
Skin lesion | 0.000271442 | 1 | 0 | BeFree |
synovial sarcoma | 0.000271442 | 1 | 0 | BeFree |
Chagas Disease | 0.000271442 | 1 | 0 | BeFree |
Tuberculosis | 0.000271442 | 1 | 0 | BeFree |
Attention Deficit Disorder | 0.000271442 | 1 | 0 | BeFree |
Urticaria Pigmentosa | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
Peripheral T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Liver Failure | 0.000271442 | 1 | 0 | BeFree |
Rous Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Myocardial Ischemia | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of gallbladder | 0.000271442 | 1 | 0 | BeFree |
Uterine Cancer | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
Obstructive chronic bronchitis with acute exacerbation | 0.000271442 | 1 | 0 | BeFree |
Porphyria Cutanea Tarda | 0.000271442 | 1 | 0 | BeFree |
Saethre-Chotzen Syndrome | 0.000271442 | 1 | 0 | BeFree |
LEOPARD Syndrome | 0.000271442 | 1 | 0 | BeFree |
Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
Klatskin Tumor | 0.000271442 | 1 | 0 | BeFree |
Rhabdoid Tumor | 0.000271442 | 1 | 0 | BeFree |
Extrapyramidal sign | 0.000271442 | 1 | 0 | BeFree |
Gallbladder Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Systemic Inflammatory Response Syndrome | 0.000271442 | 1 | 0 | BeFree |
Sepsis | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Small Cell | 0.000271442 | 1 | 1 | BeFree |
Bannayan-Riley-Ruvalcaba Syndrome | 0.000271442 | 1 | 0 | BeFree |
Polymicrogyria | 0.000271442 | 1 | 0 | BeFree |
Impaired glucose tolerance | 0.000271442 | 1 | 0 | BeFree |
Virchow's node (disorder) | 0.000271442 | 1 | 0 | BeFree |
Familial Alzheimer Disease (FAD) | 0.000271442 | 1 | 0 | BeFree |
Stage II Colon Cancer | 0.000271442 | 1 | 0 | BeFree |
Stage IV Bladder Cancer AJCC v6 | 0.000271442 | 1 | 0 | BeFree |
Prostate cancer recurrent | 0.000271442 | 1 | 0 | BeFree |
B-cell adult acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma Of Esophagus | 0.000271442 | 1 | 0 | BeFree |
Cervical Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Prostatic Intraepithelial Neoplasias | 0.000271442 | 1 | 0 | BeFree |
Carcinoid tumor no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
Ceruminous adenoma | 0.000271442 | 1 | 0 | BeFree |
Round cell liposarcoma | 0.000271442 | 1 | 0 | BeFree |
Anaplastic astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Pilocytic Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of colon | 0.000271442 | 1 | 0 | BeFree |
Impaired cognition | 0.000271442 | 1 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Juvenile Myelomonocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Chorea Acanthocytosis Syndrome | 0.000271442 | 1 | 0 | BeFree |
Lymphatic Abnormalities | 0.000271442 | 1 | 0 | BeFree |
Chronic pelvic pain of female | 0.000271442 | 1 | 0 | BeFree |
Endometrioid tumor | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
Dementia | 0.000271442 | 1 | 0 | BeFree |
Recurrent tumor | 0.000271442 | 1 | 0 | BeFree |
Increased drug resistance | 0.000271442 | 1 | 0 | BeFree |
Neurodegenerative Disorders | 0.000271442 | 1 | 0 | BeFree |
Mood Disorders | 0.000271442 | 1 | 0 | BeFree |
Myxoid/Round Cell Liposarcoma | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of skin | 0.000271442 | 1 | 0 | BeFree |
Tonsillar Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Infected ascites | 0.000271442 | 1 | 0 | BeFree |
Costello syndrome (disorder) | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of larynx | 0.000271442 | 1 | 0 | BeFree |
invasive cancer | 0.000271442 | 1 | 0 | BeFree |
Refractory cancer | 0.000271442 | 1 | 0 | BeFree |
Malignant Female Reproductive System Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Skin carcinoma | 0.000271442 | 1 | 0 | BeFree |
Biliary Tract Cancer | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm tonsil | 0.000271442 | 1 | 0 | BeFree |
Malignant Squamous Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Metastatic Endometrial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Heartburn acidity | 0.000271442 | 1 | 0 | BeFree |
Diffuse large B-cell lymphoma recurrent | 0.000271442 | 1 | 0 | BeFree |
Philadelphia chromosome positive | 0.000271442 | 1 | 0 | BeFree |
Dedifferentiated chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
latent infection | 0.000271442 | 1 | 0 | BeFree |
SHORT syndrome | 0.000271442 | 1 | 0 | BeFree |
Cerebral Ischemia | 0.000271442 | 1 | 0 | BeFree |
Arthritis, Collagen-Induced | 0.000271442 | 1 | 0 | BeFree |
Drug Resistant Epilepsy | 0.000271442 | 1 | 0 | BeFree |
High-Grade Prostatic Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Mammary Carcinoma, Human | 0.000271442 | 1 | 0 | BeFree |
Morphologically altered structure | 0.000271442 | 1 | 0 | BeFree |
Attention deficit hyperactivity disorder | 0.000271442 | 1 | 0 | BeFree |
Enterochromaffin-like cell carcinoid | 0.000271442 | 1 | 0 | BeFree |
Atypical teratoid/rhabdoid tumor | 0.000271442 | 1 | 0 | BeFree |
Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
Pancreatic intraepithelial neoplasia | 0.000271442 | 1 | 0 | BeFree |
Salivary duct carcinoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
Sendai virus infection | 0.000271442 | 1 | 0 | BeFree |
Hormone refractory prostate cancer | 0.000271442 | 1 | 0 | BeFree |
Classical Hodgkin's Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Epstein-Barr Virus-Related Lymphoma | 0.000271442 | 1 | 0 | BeFree |
External Auditory Canal Ceruminous Adenoma | 0.000271442 | 1 | 0 | BeFree |
Testicular Germ Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Granulosa cell tumor of the ovary | 0.000271442 | 1 | 0 | BeFree |
Metastatic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Angiogenic Switch | 0.000271442 | 1 | 0 | BeFree |
Tumor Promotion | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma, Endometrioid | 0.000271442 | 1 | 0 | BeFree |
androgen independent prostate cancer | 0.000271442 | 1 | 0 | BeFree |
tumor vasculature | 0.000271442 | 1 | 0 | BeFree |
MYELOID TUMOR SUPPRESSOR | 0.000271442 | 1 | 0 | BeFree |
Familial ependymoma | 0.000271442 | 1 | 0 | BeFree |
Prostate Cancer, Hereditary, 7 | 0.000271442 | 1 | 0 | BeFree |
Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome | 0.000271442 | 1 | 0 | BeFree |
PTEN Hamartoma Tumor Syndrome | 0.000271442 | 1 | 0 | BeFree |
Destructive Arthritis | 0.000271442 | 1 | 0 | BeFree |
Oropharyngeal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Allergic rhinitis (disorder) | 0.000271442 | 1 | 0 | BeFree |
Macroencephaly | 0.000271442 | 1 | 0 | BeFree |
Kashin-Beck Disease | 0.000271442 | 1 | 0 | BeFree |
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Chronic ulcerative colitis | 0.000271442 | 1 | 0 | BeFree |
Benign symmetrical lipomatosis | 0.000271442 | 1 | 0 | BeFree |
aggressive cancer | 0.000271442 | 1 | 0 | BeFree |
Fetal Alcohol Spectrum Disorders | 0.000271442 | 1 | 0 | BeFree |
Overgrowth Syndrome | 0.000271442 | 1 | 0 | BeFree |
Stage II Colon Cancer AJCC v7 | 0.000271442 | 1 | 0 | BeFree |
Primary acquired melanosis | 0.000271442 | 1 | 0 | BeFree |
MYELODYSPLASTIC SYNDROME | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。